Vectorite Biomedical Inc. (TPEX:4170)
13.45
-0.65 (-4.61%)
At close: Mar 9, 2026
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 588.72 million as of March 10, 2026. Its market cap has decreased by -3.58% in one year.
Market Cap
588.72M
Enterprise Value
412.87M
Revenue
67.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.45
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 588.72M, an increase of 49.71%. That is a compound annual growth rate of 3.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiwanJ Pharmaceuticals | 616.94M |
| SynCore Biotechnology Co.,Ltd | 745.50M |
| BioLASCO Taiwan | 751.71M |
| Eusol Biotech | 869.95M |
| TCI GENE | 881.07M |
| Neith | 899.73M |
| NatureWise Biotech & Medicals | 916.55M |
| Taiwan Advance Bio-Pharmaceutical | 945.00M |